Lupus Science & Medicine: 8 (1)

Brief communication

SARS-CoV-2 vaccines in patients with SLE (8 March, 2021)
Wei Tang, Anca D Askanase, Leila Khalili, Joan T Merrill
Patient and provider perceptions of a novel cognitive functioning report for patients with systemic lupus erythematosus: a qualitative study (24 February, 2021)
Laura Plantinga, Ann Vandenberg, Felicia Goldstein, Brian Jones, Jeremy Johnson, Christopher Barrett Bowling, Charmayne Dunlop-Thomas, Sung Sam Lim, Cristina Drenkard

Biomarker studies

Original research: Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus (18 March, 2021)
MacIntosh Grant Cornwell, Elliot S Luttrell-Williams, Michael Golpanian, Hanane El Bannoudi, Khrystyna Myndzar, Peter Izmirly, H Michael Belmont, Stuart Katz, Nathaniel R Smilowitz, Alexis Engel, Robert Clancy, Kelly Ruggles, Jill P Buyon, Jeffrey S Berger
Original research: RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin (3 March, 2021)
Joseph F Merola, Wenting Wang, Carrie G Wager, Stefan Hamann, Xueli Zhang, Alice Thai, Christopher Roberts, Christina Lam, Cristina Musselli, Galina Marsh, Dania Rabah, Catherine Barbey, Nathalie Franchimont, Taylor L Reynolds

Co-morbidities

Original research: Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years (5 February, 2021)
Sofia Ajeganova, Ingiäld Hafström, Johan Frostegård
Original research: Intracellular homocysteine metabolites in SLE: plasma S-adenosylhomocysteine correlates with coronary plaque burden (21 January, 2021)
George Stojan, Jessica Li, Tian Liu, Maureen A Kane, Michelle A Petri

Clinical trials and drug discovery

Original research: Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials (17 February, 2021)
Raj Tummala, Gabriel Abreu, Lilia Pineda, M Alex Michaels, Rubana N Kalyani, Richard A Furie, Eric F Morand

Childhood lupus

Original research: Formal neurocognitive function and anti-N-methyl-D-aspartate receptor antibodies in paediatric lupus (23 March, 2021)
Tamara K Nowling, Mary Kral, Bethany Wolf, Gary Gilkeson, Natasha McKerran Ruth

Epidemiology and outcomes

Original research: Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety (19 April, 2021)
Alain Cornet, Jeanette Andersen, Chiara Tani, Marta Mosca
Original research: Living with systemic lupus erythematosus in 2020: a European patient survey (13 April, 2021)
Alain Cornet, Jeanette Andersen, Kirsi Myllys, Angela Edwards, Laurent Arnaud
Original research: Smoking associates with distinct clinical phenotypes in patients with systemic lupus erythematosus: a nationwide Danish cross-sectional study (2 April, 2021)
Henrik Christian Bidstrup Leffers, Anne Troldborg, Anne Voss, Salome Kristensen, Jesper Lindhardsen, Prabhat Kumar, Asta Linauskas, Lars Juul, Niels Steen Krogh, Bent Deleuran, Lene Dreyer, Søren Jacobsen
Original research: Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence (1 April, 2021)
Zgjim Osmani, Thijs J Schrama, Wendy Zacouris-Verweij, Jeanette Andersen, Susan Frankel, Irene E M Bultink, Alain Cornet, Ronald F van Vollenhoven
Original research: The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research (9 February, 2021)
Karin Tse, Sanjyot Sangodkar, Lauren Bloch, Kathleen Arntsen, Sang-Cheol Bae, Ian N Bruce, Erin Connolly-Strong, Karen H Costenbader, Bradley Dickerson, Thomas Dörner, Sydney Evans, Kenneth Kalunian, Amy H Kao, Susan Manzi, Eric F Morand, Sandra C Raymond, Brad H Rovin, Laura Eve Schanberg, Joan M Von Feldt, Victoria P Werth, Angel Williams Derricott, David Zook, Timothy Franson, Kenneth Getz, Yaritza Peña, Leslie M Hanrahan
Original research: Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus (8 February, 2021)
Tasneem Lokhandwala, Binglin Yue, Anna D Coutinho, Christopher F Bell

Genetics

Original research: Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study (18 January, 2021)
Ashira Blazer, Ida Dzifa Dey, Janet Nwaukoni, Margaret Reynolds, Festus Ankrah, Huda Algasas, Tasneem Ahmed, Jasmin Divers

Immunology and inflammation

Original research: Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre (8 April, 2021)
Deanna D Hill, Amanda M Eudy, Peter J Egger, Qinggong Fu, Michelle A Petri
Original research: Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus (16 March, 2021)
Felice Rivellese, Sotiria Manou-Stathopoulou, Daniele Mauro, Katriona Goldmann, Debasish Pyne, Ravindra Rajakariar, Patrick Gordon, Peter Schafer, Michele Bombardieri, Costantino Pitzalis, Myles J Lewis
Original research: Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies (8 March, 2021)
Marit Stockfelt, Gunilla Larsson, Hanna Engström, Henri Puttonen, Henrik Zetterberg, Kaj Blennow, Christopher Sjöwall, Helena Strevens, Andreas Jönsen, Anders A Bengtsson, Maria Majczuk Sennström, Agneta Zickert, Elisabet Svenungsson, Iva Gunnarsson, Estelle Trysberg, Bo Jacobsson, Anna-Karin Hultgård Ekwall, Karin Christenson, Johan Bylund, Mattias N D Svensson, Anna-Carin Lundell
Original research: Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme (10 February, 2021)
Toni Maslen, Ian N Bruce, David D'Cruz, Mihaela Ianosev, Damon L Bass, Christel Wilkinson, David A Roth

Letter

Development and implementation of a virtual Lupus Patient Education Event during the COVID-19 pandemic (10 March, 2021)
Mithu Maheswaranathan, Jessica A English, Melissa A Cunningham, Diane L Kamen
Assessment of SLE activity for acute clinical decision-making: use of a colour-coded threat-level approach for the non-rheumatologist (12 February, 2021)
Cindy Flower

Lupus nephritis

Original research: Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis (8 February, 2021)
Huijing Wang, Yunjie Gao, Yanhong Ma, Fanghao Cai, Xiaohan Huang, Lan Lan, Pingping Ren, Yaomin Wang, Jianghua Chen, Fei Han

Reproductive health and APS

Original research: Breastfeeding in women with rheumatic diseases (8 April, 2021)
Naira Ikram, Amanda Eudy, Megan E B Clowse

Correction

Correction: SARS-CoV-2 vaccines in patients with SLE (17 March, 2021)

Main menu

Current Issue

April 2021 - Volume 8 - 1

Brief communication

Biomarker studies

Co-morbidities

Clinical trials and drug discovery

Childhood lupus

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter

Lupus nephritis

Reproductive health and APS

Correction

Log in using your username and password

Main menu

Log in using your username and password

You are here

Current Issue

April 2021 - Volume 8 - 1

Brief communication

Biomarker studies

Co-morbidities

Clinical trials and drug discovery

Childhood lupus

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter

Lupus nephritis

Reproductive health and APS

Correction